Ayman S. Tahhan

Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Emory University School of Medicine

Author of 1 Presentation

13. Heart Failure and Cardiomyopathies: Clinical 1308-140

1308-140 - L-LEUCINE: A NOVEL BIOMARKER THAT PREDICTS LOWER MORTALITY IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION

Session
1308 - Heart Failure and Cardiomyopathies: Clinical 5
Speakers
Pathway
13. Heart Failure and Cardiomyopathies: Clinical
Presentation Number
1308-140
Presentation Rating
 5

Author of 1 Presentation

13. Heart Failure and Cardiomyopathies: Clinical 1308-140

1308-140 - L-LEUCINE: A NOVEL BIOMARKER THAT PREDICTS LOWER MORTALITY IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION

Session
1308 - Heart Failure and Cardiomyopathies: Clinical 5
Speakers
Pathway
13. Heart Failure and Cardiomyopathies: Clinical
Presentation Number
1308-140
Presentation Rating
 5